Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Literature
1.
Patlas N, Golomb G, Yaffe P et al (1999) Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60:68–73CrossRefPubMed
2.
Mc Kenzie AF, Budd RS, Yang C et al (1994) Technicium-99m-methylene disphosphonate uptake in the fetal skeleton at 30 weeks gestation. J Nucl Med 35:1338–1341
3.
Cremers SC, Papapoulos SE, Gelderblom H et al (2005) Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases. J Bone Miner Res 20:1543–1547CrossRefPubMed
4.
O'Sullivan SM, Grey AB, Singh R et al (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008–1012 Epub 2006 Apr 27CrossRefPubMed
5.
Culbert EC, Schfirin BS (2006) Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions. Obstet Gynecol 108(3 Pt 2):789–791PubMed
6.
Ornoy A, Wajnberg R, Diav-Citrin O (2006) The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment. Reprod Toxicol 22:578–579CrossRefPubMed
7.
Munus CF, Rauch F, Ward L et al (2004) Maternal and fetal outcome after long-term pamidronate treatment before conception : a report of two cases. J Bone Miner Res 19:1742–1745CrossRef
8.
Chan B, Zacharin M (2006) Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab 91:2017–2020CrossRefPubMed
Metadata
Title
Maternal and fetal outcome after long-term bisphosphonate exposure before conception
Authors
S. Hassen-Zrour
W. Korbâa
I. Béjia
Z. Saidani
N. Bergaoui
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 4/2010
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-009-0983-1

Other articles of this Issue 4/2010

Osteoporosis International 4/2010 Go to the issue

Original Article

Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials

Original Article

Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians

Original Article

Progressive load training for the quadriceps muscle associated with proprioception exercises for the prevention of falls in postmenopausal women with osteoporosis: a randomized controlled trial

Original Article

Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk

Short Communication

Self-reported preclinical mobility limitation and fall history as predictors of future falls in older women: prospective cohort study

Original Article

In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization